Department of Medicine, University of Toronto, Toronto, Canada
Research Article
Exploring Strategies for Attenuating Changes in Bone Mineral Density in Men who have Sex with Men Using Tenofovir/Emtricitabine Pre-exposure Prophylaxis
Author(s): Jean-Luc Kortenaar, Angela M Cheung, Shabbir Mewa, Esther Waugh, Laurence Rubin and Darrell HS Tan*
Objective: Tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as HIV pre-exposure prophylaxis (PrEP)
decreases bone mineral density (BMD). We explored the impact of vitamin D supplementation, dietary calcium intake,
and bone loading exercise on BMD during the first 12 months of daily TDF/FTC PrEP.
Methods: All participants from the PREPARATORY-5 pilot demonstration project of gay and bisexual men were
eligible for inclusion if they had dual-energy X-ray absorptiometry scans at both baseline and 12 months (n=39). Selfreported
vitamin D supplementation was collected prospectively, whereas data on diet and exercise was obtained
retrospectively after the trial period, using validated questionnaires. We compared median percent changes in BMD
and trabecular bone score (TBS) between those with and without vitamin D supplementatio.. Read More»
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report